Clinical Trial Update: Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial update on belinostat for advanced ovarian epithelial cancer, primary peritoneal cancer, fallopian tube cancer, and ovarian low malignant potential…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Ovarian Surface Epithelial-stromal Tumor
• Fallopian Tube Carcinoma
• Ovarian Cancer
• Ovarian Epithelial Cancer
• Peritoneal Carcinoma

Drugs mentioned

• Belinostat (belinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-12-14